Avobenzone-13C,d3

CAT:
804-HY-B0316S-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Avobenzone-13C,d3 - image 1

Avobenzone-13C,d3

  • CAS Number:

    2933758-47-3
  • UNSPSC Description:

    Avobenzone-13C,d3 is the 13C- and deuterium labeled Avobenzone. Avobenzone, a dibenzoylmethane compound, is one of the most widely used filters in sunscreens for skin photoprotection in the UVA band. Avobenzone is an endocrine disruptor that directly binds to estrogen receptor β and acts as an estrogen agonist[1][2].
  • Target Antigen:

    Apoptosis; Estrogen Receptor/ERR; Isotope-Labeled Compounds
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Apoptosis;Others;Vitamin D Related/Nuclear Receptor
  • Applications:

    Metabolism-protein/nucleotide metabolism
  • Field of Research:

    Others
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O=C(C1=CC=C(C=C1)O[13C]([2H])([2H])[2H])CC(C2=CC=C(C=C2)C(C)(C)C)=O
  • Molecular Weight:

    314.40
  • References & Citations:

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.|[2]Ahn S, An S, et al. A long-wave UVA filter avobenzone induces obesogenic phenotypes in normal human epidermal keratinocytes and mesenchymal stem cells. Arch Toxicol. 2019;93(7):1903-1915.|[3]Kojić M, et al. A new insight into the photochemistry of avobenzone in gas phase and acetonitrile from ab initio calculations. Phys Chem Chem Phys. 2016;18(32):22168-22178.|[4]Schreurs RH, et al. Interaction of polycyclic musks and UV filters with the estrogen receptor (ER), androgen receptor (AR), and progesterone receptor (PR) in reporter gene bioassays. Toxicol Sci. 2005;83(2):264-272.|[5]Yang C, et al. Avobenzone suppresses proliferative activity of human trophoblast cells and induces apoptosis mediated by mitochondrial disruption. Reprod Toxicol. 2018;81:50-57.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported